best performing mid cap and large cap stocks december 1 2017 to april 1 2018

Argenx NV ADR (ARGX) had the highest return between December 1, 2017 and April 1, 2018 by a US stock with a market cap of $2B+, returning 154.1%.

ASSETDATE% RETURN
argenx NV ADR (ARGX)
12/1/2017 - 4/1/2018
154.07%
Spyre Therapeutics (SYRE)
12/1/2017 - 4/1/2018
145.54%
Crispr Therapeutics (CRSP)
12/1/2017 - 4/1/2018
139.95%
Madrigal Pharmaceuticals (MDGL)
12/1/2017 - 4/1/2018
132.19%
Vericel Corp Ord (VCEL)
12/1/2017 - 4/1/2018
118.68%
BeiGene (ONC)
12/1/2017 - 4/1/2018
109.29%
Virtu Financial (VIRT)
12/1/2017 - 4/1/2018
104.75%
Vipshop (VIPS)
12/1/2017 - 4/1/2018
103.43%
Arrowhead Pharmaceuticals (ARWR)
12/1/2017 - 4/1/2018
103.1%
Xenon Pharmaceuticals (XENE)
12/1/2017 - 4/1/2018
100%
Suzano Papel e Celulose SA ADR (SUZ)
12/1/2017 - 4/1/2018
95.01%
Acm Research (ACMR)
12/1/2017 - 4/1/2018
92.19%
Iovance Biotherapeutics (IOVA)
12/1/2017 - 4/1/2018
86.74%
Skyline (SKY)
12/1/2017 - 4/1/2018
79.15%
Ascendis Pharma A-S (ASND)
12/1/2017 - 4/1/2018
76.8%
Tenet Healthcare (THC)
12/1/2017 - 4/1/2018
72.72%
PTC Therapeutics (PTCT)
12/1/2017 - 4/1/2018
69.34%
Ecopetrol SA ADR (EC)
12/1/2017 - 4/1/2018
65.5%
Penguin Solutions (PENG)
12/1/2017 - 4/1/2018
64.38%
TG Therapeutics (TGTX)
12/1/2017 - 4/1/2018
62.29%
Enphase Energy (ENPH)
12/1/2017 - 4/1/2018
58.68%
ADMA Biologics (ADMA)
12/1/2017 - 4/1/2018
58.62%
Autohome (ATHM)
12/1/2017 - 4/1/2018
58.53%
Netflix (NFLX)
12/1/2017 - 4/1/2018
57.95%
Axon Enterprise (AXON)
12/1/2017 - 4/1/2018
57.87%